Cilostazol for HFpEF

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

July 1, 2022

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG

Cilostazol 100Mg Tab

Cilostazol Twice a Day

DRUG

Placebo

Trial Locations (1)

M Health Fairview, Minneapolis

All Listed Sponsors

lead

University of Minnesota

OTHER

NCT05126836 - Cilostazol for HFpEF | Biotech Hunter | Biotech Hunter